Watch CBS News

Philly Doctor: New Study On COVID-19 Antibodies Could Mean Potential Vaccine Would Require Multiple Doses

PHILADELPHIA (CBS) -- A new study suggests people who have recovered from COVID-19 might not have immunity to the virus for very long. A local doctor spoke with Eyewitness News about what this could mean in the race to develop a vaccine.

New research shows the body's defense against the coronavirus may not be as long-lived as first thought.

"What they're saying is, the antibody response that shows up in a person's blood may only last three to six months," Dr. Rob Danoff, the program director of family medicine at Jefferson Northeast, said.

Danoff says it's too early to tell whether this will have an impact on how effective a vaccine will be.

"Does that mean a person could get infected again with COVID-19? But here's the thing, we don't know because they weren't testing for a thing called neutralizing antibodies," Danoff said.

But a new test for so-called neutralizing antibodies has just been released by the Mayo Clinic, and it would better tell if a person could have long-term immunity to the virus.

"What they do is, they block this virus from getting into the cells," Danoff said. "It's wild, but neutralizing antibodies are what help protect us and they weren't tested, but now they are."

But even if your body's immunity only lasts a few months against COVID-19, Danoff says "the one thing I want to do is put it in perspective."

Danoff says a future COVID-19 vaccination may simply require a few trips to the doctor.

"I'm sure you've gotten vaccines where you have had boosters -- this is kind of the same thing," he said.

As for when an effective vaccine could be available, Danoff says there are more than 140 in development, about two dozen of which are making good progress. He's optimistic there could be a working vaccine by winter this year.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.